Literature DB >> 17430131

Retinal degenerations: from cell signaling to cell therapy; pre-clinical and clinical issues.

Thérese Cronin1, Thierry Léveillard, José-Alain Sahel.   

Abstract

Extracellular signaling molecules have been implicated in the progression of Retinal Degeneration (RD). Gene regulatory events linked to the maintenance of retinal structure and function incorporate signaling cascades that may serve as therapeutic targets for some forms of blindness. This review shall focus on the evidence for non-cell-autonomous mechanisms that affect the pattern of degeneration seen in retinal dystrophies, the types of signals that may influence the course of degeneration and finally with the related prospects for retinal-therapies.

Entities:  

Mesh:

Year:  2007        PMID: 17430131     DOI: 10.2174/156652307780363143

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  15 in total

1.  Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency.

Authors:  J Pang; S E Boye; B Lei; S L Boye; D Everhart; R Ryals; Y Umino; B Rohrer; J Alexander; J Li; X Dai; Q Li; B Chang; R Barlow; W W Hauswirth
Journal:  Gene Ther       Date:  2010-03-18       Impact factor: 5.250

2.  Chemical chaperone TUDCA preserves cone photoreceptors in a mouse model of Leber congenital amaurosis.

Authors:  Tao Zhang; Wolfgang Baehr; Yingbin Fu
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-05       Impact factor: 4.799

3.  Retinitis pigmentosa: cone photoreceptors starving to death.

Authors:  Paola Bovolenta; Elsa Cisneros
Journal:  Nat Neurosci       Date:  2009-01       Impact factor: 24.884

4.  Association between multifocal electroretinograms, optical coherence tomography and central visual sensitivity in advanced retinitis pigmentosa.

Authors:  Chan Hee Moon; Tae Kwann Park; Young-Hoon Ohn
Journal:  Doc Ophthalmol       Date:  2012-08-03       Impact factor: 2.379

5.  ℮-conome: an automated tissue counting platform of cone photoreceptors for rodent models of retinitis pigmentosa.

Authors:  Emmanuelle Clérin; Nicolas Wicker; Saddek Mohand-Saïd; Olivier Poch; José-Alain Sahel; Thierry Léveillard
Journal:  BMC Ophthalmol       Date:  2011-12-20       Impact factor: 2.209

6.  Requirement of the Mowat-Wilson Syndrome Gene Zeb2 in the Differentiation and Maintenance of Non-photoreceptor Cell Types During Retinal Development.

Authors:  Wen Wei; Bin Liu; Haisong Jiang; Kangxin Jin; Mengqing Xiang
Journal:  Mol Neurobiol       Date:  2018-06-19       Impact factor: 5.590

7.  Predicting Progression of ABCA4-Associated Retinal Degenerations Based on Longitudinal Measurements of the Leading Disease Front.

Authors:  Artur V Cideciyan; Malgorzata Swider; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

8.  Expression of rod-derived cone viability factor: dual role of CRX in regulating promoter activity and cell-type specificity.

Authors:  Sophie Lambard; Sacha Reichman; Cynthia Berlinicke; Marie-Laure Niepon; Olivier Goureau; José-Alain Sahel; Thierry Léveillard; Donald J Zack
Journal:  PLoS One       Date:  2010-10-07       Impact factor: 3.240

9.  Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa.

Authors:  Ying Yang; Saddek Mohand-Said; Aude Danan; Manuel Simonutti; Valérie Fontaine; Emmanuelle Clerin; Serge Picaud; Thierry Léveillard; José-Alain Sahel
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

10.  The thioredoxin-like protein rod-derived cone viability factor (RdCVFL) interacts with TAU and inhibits its phosphorylation in the retina.

Authors:  Ram Fridlich; Francois Delalande; Céline Jaillard; Jun Lu; Laetitia Poidevin; Thérèse Cronin; Ludivine Perrocheau; Géraldine Millet-Puel; Marie-Laure Niepon; Olivier Poch; Arne Holmgren; Alain Van Dorsselaer; Jose-Alain Sahel; Thierry Léveillard
Journal:  Mol Cell Proteomics       Date:  2009-03-11       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.